MERZOUKI ABDERRAZZAK (Chief Operating Officer) received a stock award from SUNSHINE BIOPHARMA INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/28/2018ACC: 0001128732-18-000008
DirectorOfficer· Chief Operating Officer
Since Aug 2018
+27M
Net shares
Net buyer
$27.0K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
27M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+27M
Price / share
$0.00
Trade value
$27K
% of position
50.5%
6/20/2018
53.47M→80.47M
Total
Net shares
+27M
Net value
$27K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/20/2018 | A · Award | +27M | $0.00 | $27K | 50.5% | 53.47M | 80.47M |
| Total | +27M | $27K | ||||||
Derivative Transactions0
No derivative transactions reported